On the other hand, non‐transgenic models that inject tau or Aβ, while mimicking elevated levels of these proteins and their independent effects on the brain, often fail to reproduce the gradual progression of AD observed in humans.124. This evidence concerns the gene MAPT and Alzheimer disease.